Patents Assigned to Riace Establishment
  • Patent number: 5672601
    Abstract: Compounds of general formula (I) ##STR1## wherein R and R.sub.1, different from each other, are a straight or branched C.sub.2 -C.sub.8 acyl group; a group of formula --CH.sub.2 -- (A)--B wherein: A is a single bond between two carbon atoms, or a group of formula --CH--CH, --CH.sub.2 --CO--, B is a C.sub.6 -C.sub.10 aryl group, optionally substituted, at the ortho-meta- and para-positions, with one or more substituents, which are the same or different, selected from the group consisting of CONHR, carboxyl, cyano, nitro, NHCOR; an aromatic heterocyclic or alicyclic group with 5 or 6 members in the ring, optionally benzocondensed, having at least one heteroatom selected from nitrogen, oxygen, sulfur, said heterocyclic group optionally having one or more substituents as described above for the aryl group; with the proviso that when one of R or R.sub.1 is the propionyl group, the other can not be the cinnamyl group or the p-nitrocinnamyl group, and when R is the propionyl group, R.sub.
    Type: Grant
    Filed: August 22, 1996
    Date of Patent: September 30, 1997
    Assignee: Riace Establishment
    Inventor: Giorgio Cignarella
  • Patent number: 4918062
    Abstract: A pharmaceutical composition containing L-.alpha.-glycerylphosphorylcolamine as the principal active ingredient for use in the treatment of chronic cerebral psycho-organic syndromes of the involutive kind or due to cerebrovascular insufficiency.
    Type: Grant
    Filed: November 30, 1988
    Date of Patent: April 17, 1990
    Assignee: Riace Establishment
    Inventor: Rosanna Lodi